Human Health Effects of Drinking Water Exposures to Per- and Polyfluoroalkyl Substances (PFAS) at Pease International Tradeport, Portsmouth, NH (The Pease Study)

ICR 201909-0923-001

OMB: 0923-0061

Federal Form Document

Forms and Documents
Document
Name
Status
Form
Unchanged
Form
Unchanged
Form
Unchanged
Form
Unchanged
Form
Unchanged
Form
Unchanged
Form
Unchanged
Form
Unchanged
Form
Unchanged
Form
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Supplementary Document
2019-09-05
Supplementary Document
2019-09-05
Supplementary Document
2019-09-05
Justification for No Material/Nonsubstantive Change
2019-09-05
Supporting Statement B
2019-08-16
Supporting Statement A
2019-08-16
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2019-08-15
Supplementary Document
2018-12-20
Supplementary Document
2018-12-20
ICR Details
0923-0061 201909-0923-001
Historical Active 201908-0923-001
HHS/TSDR 0923-0061
Human Health Effects of Drinking Water Exposures to Per- and Polyfluoroalkyl Substances (PFAS) at Pease International Tradeport, Portsmouth, NH (The Pease Study)
No material or nonsubstantive change to a currently approved collection   No
Regular
Approved without change 09/10/2019
Retrieve Notice of Action (NOA) 09/05/2019
Previous terms continue: Consistent with the Supporting Statement, the statistical power and sampling frame of this proof of concept study limits ATSDR’s ability to detect moderate differences (between exposed and nonexposed individuals) in many of health conditions queried in this collection. Approval for the collection of information about conditions for which there is not adequate statistical power is provided specifically for the purposes of evaluating the study procedures, methods, and hypotheses for a future multi-site study. Approval is provided contingent upon a commitment to investigate other contributing environmental factors when associations or trends are observed between PFAS exposure and health conditions. Approval is also provided contingent upon a commitment to work with the National Center for Health Statistics on disclosure review procedures and include a member of NCHS’s disclosure review board for NHANES on the PEAS disclosure review board.
  Inventory as of this Action Requested Previously Approved
08/31/2022 08/31/2022 08/31/2022
5,852 0 5,852
1,454 0 1,454
42,227 0 42,227

The Pease Study will serve as a proof-of-concept model for a multi-site study of PFAS health effects. The existence of a large body of state and local environmental monitoring and population blood testing data makes the Pease community in Portsmouth, NH particularly suitable as ATSDR’s initial PFAS research study site. The main goals of the research study are to: 1) evaluate the study procedures and methods to identify any changes to the design or protocol that need to be made before embarking on a multi-site study; and 2) examine associations between a limited number of health outcomes for which statistical power is adequate and measured and historically reconstructed serum levels of PFAS (e.g., lipids, renal function and kidney disease, thyroid hormones and disease, liver function and disease, glycemic parameters and diabetes, as well as immune response and function in both children and adults). Request for change to retain leftover blood with participant consent.

US Code: 42 USC 301 Name of Law: PHSA
   PL: Pub.L. 115 - 141 8006 Name of Law: Consolidated Appropriations Act
   US Code: 42 USC 9604 Name of Law: CERCLA
  
None

Not associated with rulemaking

  83 FR 43685 08/27/2018
84 FR 3449 02/12/2019
Yes

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 5,852 5,852 0 0 0 0
Annual Time Burden (Hours) 1,454 1,454 0 0 0 0
Annual Cost Burden (Dollars) 42,227 42,227 0 0 0 0
No
No
This is a resubmission of a new ICR.

$1,912,122
Yes Part B of Supporting Statement
    Yes
    Yes
No
No
No
Uncollected
Shari Steinberg 404 639-4942 shari.steinberg@cdc.hhs.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
09/05/2019


© 2024 OMB.report | Privacy Policy